Related Experiment Video

Updated: Jun 21, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Treatment options for hepatitis C and the rationale for low response rates in African Americans

Cheu Manka1, Ralph Gomes, Rebecca Reviere

  • 1Department of Biology, Howard University, Washington, DC, USA. m_cheu@hotmail.com

Journal of the National Medical Association
|July 10, 2009
PubMed

Insights

Hepatitis C virus (HCV) disproportionately affects African Americans, who show different disease progression and treatment responses. This study reviews HCV treatment options and explores reasons for these racial disparities.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection affects 170 million globally, posing a significant public health challenge.
  • Racial and ethnic disparities in HCV treatment and outcomes are a critical concern in the United States.
  • African Americans exhibit higher HCV prevalence, lower viral clearance rates, and potentially slower fibrosis progression compared to Caucasians.

Purpose of the Study:

  • To summarize current Hepatitis C virus treatment options for African Americans.
  • To elucidate the mechanisms underlying differential treatment responses in African Americans with HCV.

Main Methods:

  • Literature review of studies focusing on HCV treatment in diverse populations.
  • Analysis of data on viral clearance, chronic infection rates, and fibrosis progression across racial groups.
  • Exploration of immunological and genetic factors potentially influencing treatment efficacy.

Main Results:

  • African Americans experience unique challenges in achieving viral clearance for Hepatitis C virus.
  • Specific genetic or immunological factors may contribute to varied responses to HCV therapies.
  • While fibrosis progression may be slower, the overall burden of chronic HCV remains high in this demographic.

Conclusions:

  • Understanding racial disparities in HCV is crucial for developing equitable treatment strategies.
  • Further research into the mechanisms of disparate treatment responses is needed.
  • Tailored interventions may improve outcomes for African Americans affected by Hepatitis C virus.

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...